Baxter International Inc (BAX):企業の財務・戦略的SWOT分析

◆英語タイトル:Baxter International Inc (BAX) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1595
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:71
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Baxter International Inc (BAX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Baxter International Inc (Baxter) is a provider of healthcare products, including dialysis in acute and chronic conditions, sterile intravenous solutions, parenteral nutrition therapies, generic injectable pharmaceuticals, infusion systems and devices, inhaled anesthetics, and surgical hemostat and sealant products. The company’s products find application in hospitals, kidney dialysis centers, rehabilitation centers, nursing homes and clinics, besides patients at home under physician supervision. Baxter distributes products through direct sales force and also through a network of independent distributors, drug wholesalers, specialty pharmacies and other alternative site providers. The company has operations in the Americas, the Middle East, Africa, Europe and Asia-Pacific. Baxter is headquartered in Deerfield, Illinois, the US.

Baxter International Inc Key Recent Developments

Apr 15,2020 Baxter provides update on COVID-19 response efforts
Mar 17,2020 Baxter reports fourth-quarter and full-year 2019 results, completes financial restatement process
Jan 12,2020 Baxter announces preliminary net sales for the fourth-quarter and full-year 2019 and announces preliminary full-year 2020 guidance
Jan 09,2020 Pomerantz law firm investigates claims on behalf of investors of Baxter

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Baxter International Inc – Key Facts
Baxter International Inc – Key Employees
Baxter International Inc – Key Employee Biographies
Baxter International Inc – Major Products and Services
Baxter International Inc – History
Baxter International Inc – Company Statement
Baxter International Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Baxter International Inc – Business Description
Product Category: Acute Therapies
Overview
Performance
Product Category: Advanced Surgery
Overview
Performance
Product Category: Clinical Nutrition
Overview
Performance
Product Category: Medication Delivery
Overview
Performance
Product Category: Other
Overview
Performance
Product Category: Pharmaceuticals
Overview
Performance
Product Category: Renal Care
Overview
Performance
Geographical Segment: Americas
Target Markets
Performance
Geographical Segment: APAC
Target Markets
Performance
Geographical Segment: EMEA
Performance
R&D Overview
Baxter International Inc – Corporate Strategy
Baxter International Inc – SWOT Analysis
SWOT Analysis – Overview
Baxter International Inc – Strengths
Baxter International Inc – Weaknesses
Baxter International Inc – Opportunities
Baxter International Inc – Threats
Baxter International Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Baxter International Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Baxter International Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Baxter International Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 15, 2020: Baxter provides update on COVID-19 response efforts
Mar 17, 2020: Baxter reports fourth-quarter and full-year 2019 results, completes financial restatement process
Jan 12, 2020: Baxter announces preliminary net sales for the fourth-quarter and full-year 2019 and announces preliminary full-year 2020 guidance
Jan 09, 2020: Pomerantz law firm investigates claims on behalf of investors of Baxter
Dec 02, 2019: Rosen, a highly ranked firm, announces filing of securities class action lawsuit against Baxter International
Nov 06, 2019: Baxter and Ayogo launch CKD&Me patient empowering digital education tool at Kidney Week 2019
Oct 24, 2019: Baxter reports preliminary third quarter 2019 operating results
Sep 11, 2019: Baxter to buy Cheetah Medical in $230m deal
Aug 21, 2019: The Baxter International Foundation and Direct Relief launch program to improve diabetes care in underserved communities
Jul 30, 2019: Baxter recognized with Highest Achievement on 2019 Diversity Best Practices Inclusion Index
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Baxter International Inc, Key Facts
Baxter International Inc, Key Employees
Baxter International Inc, Key Employee Biographies
Baxter International Inc, Major Products and Services
Baxter International Inc, History
Baxter International Inc, Subsidiaries
Baxter International Inc, Joint Venture
Baxter International Inc, Key Competitors
Baxter International Inc, Ratios based on current share price
Baxter International Inc, Annual Ratios
Baxter International Inc, Annual Ratios (Cont...1)
Baxter International Inc, Annual Ratios (Cont...2)
Baxter International Inc, Interim Ratios
Baxter International Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Baxter International Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Baxter International Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Baxter International Inc, Performance Chart (2015 - 2019)
Baxter International Inc, Ratio Charts
Baxter International Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Baxter International Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Baxter International Inc (BAX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Interpace Diagnostics Group Inc (IDXG)-医療機器分野:企業M&A・提携分析
    Summary Interpace Diagnostics Group Inc (Interpace Diagnostics), formerly PDI Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathfinder platform; a …
  • Bryte Insurance Company Ltd:企業の戦略・SWOT・財務情報
    Bryte Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Bryte Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Juniper Pharmaceuticals Inc (JNP):製薬・医療:M&Aディール及び事業提携情報
    Summary Juniper Pharmaceuticals Inc (Juniper), formerly Columbia Laboratories Inc is a women’s health therapeutic company that focuses on developing therapeutics that address unmet medical needs. It develops, manufactures, licenses and sells pharmaceutical products in women's health. The company uti …
  • Nuclear Power Corporation of India Ltd:企業の戦略的SWOT分析
    Nuclear Power Corporation of India Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Euticals SpA-製薬・医療分野:企業M&A・提携分析
    Summary Euticals SpA (Euticals) is a chemical company that develops and supplies active pharmaceutical ingredients, fine chemicals and contract manufacturing. The company possess technologies and capabilities in the domains of fermentation and enzymatic chemistry; boronic acids, biaryls, grignards a …
  • Mitsubishi Tanabe Pharma Corp (4508):企業の財務・戦略的SWOT分析
    Mitsubishi Tanabe Pharma Corp (4508) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Xbrane Biopharma AB (XBRANE):製薬・医療:M&Aディール及び事業提携情報
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products. The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It combi …
  • Bharat Sanchar Nigam Ltd:企業の戦略的SWOT分析
    Bharat Sanchar Nigam Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Miltenyi Biotec GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Miltenyi Biotec GmbH (Miltenyi) is a biotechnology company that offers biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture. The company offers sample preparation, cell separation, flow cytometry, cell culture and stimulati …
  • Steris Corp-医療機器分野:企業M&A・提携分析
    Summary Steris Corp (Steris), formerly Innovative Medical Technologies, a subsidiary of Steris Plc, is a medical device company that offers infection prevention and other procedural products and services. The company offers surgical equipment and image management, sterile processing equipment, surgi …
  • Under Armour, Inc.:企業の戦略・SWOT・財務情報
    Under Armour, Inc. - Strategy, SWOT and Corporate Finance Report Summary Under Armour, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析
    Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Bone Therapeutics SA (BOTHE):医療機器:M&Aディール及び事業提携情報
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fracture …
  • ROHM Co Ltd (6963):企業の財務・戦略的SWOT分析
    ROHM Co Ltd (6963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Norwegian Air Shuttle ASA:戦略・SWOT・企業財務分析
    Norwegian Air Shuttle ASA - Strategy, SWOT and Corporate Finance Report Summary Norwegian Air Shuttle ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Puracap Pharmaceutical LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Puracap Pharmaceutical LLC (PuraCap) is a drug development company that offers prescription generics and OTC products. The company provides over the counter soft gels and oral solid dosage healthcare products for upper respiratory, pain relief, cough and cold, sleep aid, gastrointestinal, an …
  • AbbVie Inc (ABBV)-製薬・医療分野:企業M&A・提携分析
    Summary AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company focuses on providing drugs in immunology, cancer, neuroscience and virology …
  • Alesi Surgical Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Alesi Surgical Ltd (Alesi Surgical), formerly Asalus Medical Instruments Ltd, is a medical device company that develops and markets laparoscopic surgical smoke handling systems. The company offers Ultravision, a system that removes laparoscopic surgical smoke without the need for gas exchang …
  • Caixa Economica Federal
    Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report Summary Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • H.I.G. Capital LLC:企業の戦略的SWOT分析
    H.I.G. Capital LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆